BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25288173)

  • 1. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report.
    Scheffer HJ; Melenhorst MC; Vogel JA; van Tilborg AA; Nielsen K; Kazemier G; Meijerink MR
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):760-5. PubMed ID: 25288173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
    Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
    J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
    MÃ¥nsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
    Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
    Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
    Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
    J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
    Marsanic P; Mellano A; Sottile A; De Simone M
    Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report.
    Bagla S; Papadouris D
    J Vasc Interv Radiol; 2012 Jan; 23(1):142-5. PubMed ID: 22221480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early nontumorous CT findings after irreversible electroporation of locally advanced pancreatic cancer.
    Schulz B; Ou J; Van Meter T; Martin RC
    Abdom Radiol (NY); 2016 Nov; 41(11):2142-2149. PubMed ID: 27351439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience.
    Belfiore MP; Ronza FM; Romano F; Ianniello GP; De Lucia G; Gallo C; Marsicano C; Di Gennaro TL; Belfiore G
    Int J Surg; 2015 Sep; 21 Suppl 1():S34-9. PubMed ID: 26118600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery.
    Martin RC; Durham AN; Besselink MG; Iannitti D; Weiss MJ; Wolfgang CL; Huang KW
    J Surg Oncol; 2016 Dec; 114(7):865-871. PubMed ID: 27546233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
    Vroomen LGPH; Scheffer HJ; Melenhorst MCAM; de Jong MC; van den Bergh JE; van Kuijk C; van Delft F; Kazemier G; Meijerink MR
    Eur Radiol; 2017 Jun; 27(6):2521-2531. PubMed ID: 27659702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
    Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
    Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas.
    Dunki-Jacobs EM; Philips P; Martin RC
    J Am Coll Surg; 2014 Feb; 218(2):179-87. PubMed ID: 24315888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer.
    Paiella S; Salvia R; Girelli R; Frigerio I; Giardino A; D'Onofrio M; De Marchi G; Bassi C
    Updates Surg; 2016 Sep; 68(3):307-311. PubMed ID: 27535401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
    Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible electroporation of pancreatic adenocarcinoma: a primer for the radiologist.
    Rashid MF; Hecht EM; Steinman JA; Kluger MD
    Abdom Radiol (NY); 2018 Feb; 43(2):457-466. PubMed ID: 29051982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.